Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Calpain Inhibitor I (ALLN) Overview

    2026-10-09

    Product identity

    Calpain Inhibitor I, ALLN is listed by APExBIO as SKU A2602 and CAS 110044-82-1. The supplier describes it as a small-molecule inhibitor with activity against calpain I, calpain II, cathepsin B, and cathepsin L.

    Conceptual research scope

    Based on the supplied product information, ALLN is positioned for protease-focused research involving apoptosis assay design, caspase activation studies, inflammation research, and ischemia-reperfusion injury model investigations. These descriptions indicate intended research contexts rather than established clinical or diagnostic applications.

    Evidence limitations

    No matched peer-reviewed paper evidence was supplied for this overview. Accordingly, the target profile and research-use context are reported as supplier-documented claims, not independently verified performance findings. Applicability may vary with biological system, assay design, compound handling, and selectivity requirements. The product should not be interpreted as a validated therapeutic, diagnostic reagent, or broadly selective calpain probe without additional evidence.